We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+0.39%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$69.6B
AUM Growth
+$2.44B
Cap. Flow
+$2.78B
Cap. Flow %
4%
Top 10 Hldgs %
16.69%
Holding
760
New
59
Increased
405
Reduced
179
Closed
58

Top Buys

Rank Stock Value
1
AIG icon
American International
AIG
+$473M
2
HPQ icon
HP
HPQ
+$383M
3
OXY icon
Occidental Petroleum
OXY
+$349M
4
TGT icon
Target
TGT
+$343M
5
CI icon
Cigna
CI
+$229M

Sector Composition

Rank Sector Weight
1 Financials 26.04%
2 Technology 15.47%
3 Healthcare 15.3%
4 Industrials 11.92%
5 Consumer Discretionary 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MPC icon
51
Marathon Petroleum
MPC
$90.9B
$393M 0.56%
7,509,432
-4,630,970
-38% -$236M
TT icon
52
Trane Technologies
TT
$107B
$380M 0.55%
5,633,852
+704,777
+14% +$48.2M
OCR
53
DELISTED
OMNICARE INC
OCR
$369M 0.53%
3,917,444
-3,730,255
-49% -$333M
RJF icon
54
Raymond James Financial
RJF
$32.4B
$364M 0.52%
9,171,444
+1,153,263
+14% +$44.8M
OMC icon
55
Omnicom Group
OMC
$22.8B
$361M 0.52%
5,188,509
+283,941
+6% +$21.4M
TRV icon
56
Travelers Companies
TRV
$80.9B
$359M 0.52%
3,718,718
-1,139,751
-23% -$117M
ON icon
57
ON Semiconductor
ON
$34.1B
$349M 0.5%
29,854,789
-1,956,250
-6% -$24M
TGT icon
58
Target
TGT
$62.3B
$346M 0.5%
+4,243,475
New +$343M
HUN icon
59
Huntsman Corp
HUN
$2.25B
$346M 0.5%
15,680,174
-119,282
-0.8% -$2.7M
DOX icon
60
Amdocs
DOX
$5.57B
$344M 0.49%
6,304,108
+849,476
+16% +$46.7M
CNQ icon
61
Canadian Natural Resources
CNQ
$97B
$343M 0.49%
26,109,074
-137,976
-0.5% -$2.08M
LHX icon
62
L3Harris
LHX
$56.2B
$342M 0.49%
4,450,559
+2,035,099
+84% +$161M
VZ icon
63
Verizon
VZ
$189B
$342M 0.49%
7,330,050
+151,484
+2% +$7.42M
PRU icon
64
Prudential Financial
PRU
$41.5B
$326M 0.47%
3,722,256
-874,201
-19% -$74.2M
RHI icon
65
Robert Half
RHI
$3.69B
$319M 0.46%
5,751,760
+963,963
+20% +$55.1M
IP icon
66
International Paper
IP
$20.4B
$313M 0.45%
6,944,363
-111,193
-2% -$5.51M
AMTD
67
DELISTED
TD Ameritrade Holding Corp
AMTD
$311M 0.45%
8,459,624
+1,095,779
+15% +$40.7M
AVY icon
68
Avery Dennison
AVY
$12.2B
$305M 0.44%
5,010,267
-741,775
-13% -$43.1M
MET icon
69
MetLife
MET
$60.5B
$305M 0.44%
6,103,457
-26,009
-0.4% -$1.23M
ABBV icon
70
AbbVie
ABBV
$458B
$301M 0.43%
4,481,334
-2,734,032
-38% -$178M
GAP
71
The Gap Inc
GAP
$6.92B
$295M 0.42%
7,735,554
+110,066
+1% +$4.35M
EFX icon
72
Equifax
EFX
$20.6B
$295M 0.42%
3,039,309
+407,909
+16% +$39.8M
PH icon
73
Parker-Hannifin
PH
$126B
$292M 0.42%
2,510,978
+139,011
+6% +$16.8M
CI icon
74
Cigna
CI
$76.4B
$291M 0.42%
1,798,843
+1,660,226
+1,198% +$229M
NWL icon
75
Newell Brands
NWL
$2.17B
$290M 0.42%
7,061,002
+957,377
+16% +$38.4M

Similar funds

Boston Partners's Q2 2015 Portfolio in Review

As of Q2 2015, Boston Partners held 760 positions worth $69.6B, up 3.6% from $67.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boston Partners deployed $2.78B of net new capital in Q2 2015, opening 59 new positions and adding to 405 existing holdings. Its largest new stake was Target: 4,243,475 shares worth $346M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was OMNICARE INC, an estimated $333M trimmed.

  • Boston Partners's largest Q2 2015 buy was Target: 4,243,475 shares worth $346M.
  • Boston Partners added most to American International in Q2 2015, an estimated $473M increase.
  • Boston Partners's biggest Q2 2015 reduction was OMNICARE INC, cutting an estimated $333M.
  • Boston Partners fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $244M.
  • Boston Partners's ten largest holdings make up 17% of its $69.6B portfolio in Q2 2015.
  • Boston Partners opened 59 new positions and closed 58 in Q2 2015.
  • Boston Partners's portfolio value rose 3.6% quarter-over-quarter to $69.6B.

Based on Boston Partners's 13F filing for Q2 2015, filed 10 Aug 2015.